{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:27:40Z","timestamp":1790375260761,"version":"4.1.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["DK093608"],"award-info":[{"award-number":["DK093608"]}]},{"name":"NIH","award":["DK46718-24"],"award-info":[{"award-number":["DK46718-24"]}]},{"name":"NIH","award":["P01 DK11794"],"award-info":[{"award-number":["P01 DK11794"]}]},{"DOI":"10.13039\/100000918","name":"New York Community Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000918","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:48:35Z","timestamp":1529351315000},"page":"685-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Phosphate homeostasis disorders"],"prefix":"10.1016","volume":"32","author":[{"given":"Marta","family":"Christov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.06.004_bib1","series-title":"Calcium, phosphate, and magnesium metabolism : clinical physiology and diagnostic procedures. Edinburgh","author":"Nordin","year":"1976"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jc.2011-1319","article-title":"Approach to the hypophosphatemic patient","volume":"97","author":"Imel","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.004_bib3","series-title":"Textbook of nephro-endocrinology","author":"Singh","year":"2009"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-3476(87)80559-0","article-title":"Sequential calcium and phosphorus balance studies in preterm infants","volume":"110","author":"Giles","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1359\/jbmr.1997.12.2.159","article-title":"Cellular and molecular mechanisms of renal phosphate transport","volume":"12","author":"Tenenhouse","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/153537020222700811","article-title":"Basolateral phosphate transport in renal proximal-tubule-like OK cells","volume":"227","author":"Barac-Nieto","year":"2002","journal-title":"Exp Biol Med (Maywood)."},{"issue":"3\u20134","key":"10.1016\/j.beem.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00384343","article-title":"Localization of NaPi-1, a Na-Pi cotransporter, in rabbit kidney proximal tubules. I. mRNA localization by reverse transcription\/polymerase chain reaction","volume":"424","author":"Custer","year":"1993","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"22","key":"10.1016\/j.beem.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1074\/jbc.M200943200","article-title":"Growth-related renal type II Na\/Pi cotransporter","volume":"277","author":"Segawa","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00424-003-1010-6","article-title":"Cloning, gene structure and dietary regulation of the type-IIc Na\/Pi cotransporter in the mouse kidney","volume":"446","author":"Ohkido","year":"2003","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"24","key":"10.1016\/j.beem.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.95.24.14564","article-title":"Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine","volume":"95","author":"Hilfiker","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.2000.80.4.1373","article-title":"Proximal tubular phosphate reabsorption: molecular mechanisms","volume":"80","author":"Murer","year":"2000","journal-title":"Physiol Rev"},{"issue":"14","key":"10.1016\/j.beem.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1073\/pnas.93.14.7409","article-title":"Structure of murine and human renal type II Na+-phosphate cotransporter genes (Npt2 and NPT2)","volume":"93","author":"Hartmann","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.beem.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.91.15.7071","article-title":"Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters","volume":"91","author":"Kavanaugh","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00424-003-1088-x","article-title":"The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors","volume":"447","author":"Collins","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jcem-43-5-1056","article-title":"Dietary phosphate deprivation in women and men: effects on mineral and acid balances, parathyroid hormone and the metabolism of 25-OH-vitamin D","volume":"43","author":"Dominguez","year":"1976","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5 Pt 2","key":"10.1016\/j.beem.2018.06.004_bib16","first-page":"F900","article-title":"Cellular mechanisms of acute and chronic adaptation of rat renal P(i) transporter to alterations in dietary P(i)","volume":"267","author":"Levi","year":"1994","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI119289","article-title":"Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content","volume":"99","author":"Lotscher","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib18","doi-asserted-by":"crossref","first-page":"F587","DOI":"10.1152\/ajprenal.00097.2004","article-title":"Internalization of renal type IIc Na-Pi cotransporter in response to a high-phosphate diet","volume":"288","author":"Segawa","year":"2005","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000107069","article-title":"New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter","volume":"27","author":"Miyamoto","year":"2007","journal-title":"Am J Nephrol"},{"issue":"4 Pt 2","key":"10.1016\/j.beem.2018.06.004_bib20","first-page":"F784","article-title":"Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules","volume":"268","author":"Kempson","year":"1995","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1073\/pnas.95.4.1909","article-title":"Parathyroid hormone leads to the lysosomal degradation of the renal type II Na\/Pi cotransporter","volume":"95","author":"Pfister","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"F792","DOI":"10.1152\/ajprenal.2000.278.5.F792","article-title":"Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-P(i) cotransporter","volume":"278","author":"Traebert","year":"2000","journal-title":"Am J Physiol Ren Physiol"},{"issue":"36","key":"10.1016\/j.beem.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1074\/jbc.M116.744052","article-title":"Convergent signaling pathways regulate parathyroid hormone and fibroblast growth Factor-23 action on NPT2A-mediated phosphate transport","volume":"291","author":"Sneddon","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"6891","key":"10.1016\/j.beem.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nature00816","article-title":"Na(+)\/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling","volume":"417","author":"Mahon","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1681\/ASN.V112222","article-title":"Parathyroid hormone stimulates extracellular signal-regulated kinase (ERK) activity through two independent signal transduction pathways: role of ERK in sodium-phosphate cotransport","volume":"11","author":"Lederer","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00424-002-0969-8","article-title":"Involvement of the MAPK-kinase pathway in the PTH-mediated regulation of the proximal tubule type IIa Na+\/Pi cotransporter in mouse kidney","volume":"446","author":"Bacic","year":"2003","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00424-003-1057-4","article-title":"Impaired PTH-induced endocytotic down-regulation of the renal type IIa Na+\/Pi-cotransporter in RAP-deficient mice with reduced megalin expression","volume":"446","author":"Bacic","year":"2003","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1074\/jbc.M211775200","article-title":"Parathyroid hormone regulation of type II sodium-phosphate cotransporters is dependent on an A kinase anchoring protein","volume":"278","author":"Khundmiri","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"e34764","DOI":"10.1371\/journal.pone.0034764","article-title":"A\u00a0new human NHERF1 mutation decreases renal phosphate transporter NPT2a expression by a PTH-independent mechanism","volume":"7","author":"Courbebaisse","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0802836","article-title":"NHERF1 mutations and responsiveness of renal parathyroid hormone","volume":"359","author":"Karim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.beem.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1056\/NEJMc086284","article-title":"NHERF1 mutations and responsiveness of renal parathyroid hormone","volume":"359","author":"Bergwitz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1124\/mol.108.054486","article-title":"NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding","volume":"75","author":"Wang","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib33","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.beem.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"Consortium A","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jbmr.2792","article-title":"Conditional deletion of murine Fgf23: interruption of the normal skeletal responses to phosphate challenge and rescue of genetic hypophosphatemia","volume":"31","author":"Clinkenbeard","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"F132","DOI":"10.1152\/ajprenal.00081.2017","article-title":"Acute blood loss stimulates fibroblast growth factor 23 production","volume":"314","author":"Rabadi","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib41","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","article-title":"Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury","volume":"93","author":"Toro","year":"2018","journal-title":"Kidney Int"},{"issue":"7120","key":"10.1016\/j.beem.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib43","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in\u00a0vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","article-title":"Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4","volume":"306","author":"Gattineni","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"issue":"46","key":"10.1016\/j.beem.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in\u00a0vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"4214","key":"10.1016\/j.beem.2018.06.004_bib54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.1188357","article-title":"Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat","volume":"190","author":"Hughes","year":"1975","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib55","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1172\/JCI110912","article-title":"Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets","volume":"71","author":"Insogna","year":"1983","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/endo.142.5.8119","article-title":"Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression","volume":"142","author":"Yoshida","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1006\/bbrc.1997.6541","article-title":"Regulation of renal vitamin D-24-hydroxylase by phosphate: effects of hypophysectomy, growth hormone and insulin-like growth factor I","volume":"233","author":"Wu","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"1 Pt 2","key":"10.1016\/j.beem.2018.06.004_bib58","first-page":"F203","article-title":"Expression of the renal 25-hydroxyvitamin D-24-hydroxylase gene: regulation by dietary phosphate","volume":"271","author":"Wu","year":"1996","journal-title":"Am J Physiol"},{"issue":"23","key":"10.1016\/j.beem.2018.06.004_bib59","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.1074\/jbc.273.23.14575","article-title":"Regulation of type II renal Na+-dependent inorganic phosphate transporters by 1,25-dihydroxyvitamin D3. Identification of a vitamin D-responsive element in the human NAPi-3 gene","volume":"273","author":"Taketani","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneph0124","article-title":"Hypophosphatemia: an evidence-based approach to its clinical consequences and management","volume":"2","author":"Amanzadeh","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9343(92)90740-3","article-title":"Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia","volume":"92","author":"Singhal","year":"1992","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib62","first-page":"165","article-title":"Rhabdomyolysis complicating unrecognized hypophosphatemia in an alcoholic patient","volume":"13","author":"Kumar","year":"1999","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.1711170404","article-title":"Nature of muscular change in osteomalacia: light- and electron-microscope observations","volume":"117","author":"Dastur","year":"1975","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.beem.2018.06.004_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/194877a0","article-title":"A\u00a0direct relationship between adenosine triphosphate-level and in\u00a0vivo viability of erythrocytes","volume":"194","author":"Nakao","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.06.004_bib65","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/oxfordjournals.jbchem.a127333","article-title":"Adenosine triphosphate and shape of erythrocytes","volume":"49","author":"Nakao","year":"1961","journal-title":"J\u00a0Biochem"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.10071","article-title":"Severe hypophosphatemia: a rare cause of intravascular hemolysis","volume":"69","author":"Melvin","year":"2002","journal-title":"Am J Hematol"},{"issue":"26","key":"10.1016\/j.beem.2018.06.004_bib67","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM197112232852602","article-title":"Acute hemolytic anemia with rigid red cells in hypophosphatemia","volume":"285","author":"Jacob","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"7\u20138","key":"10.1016\/j.beem.2018.06.004_bib68","first-page":"429","article-title":"Reduced function of neutrophils during routine postoperative glucose infusion","volume":"154","author":"Rasmussen","year":"1988","journal-title":"Acta Chir Scand"},{"issue":"25","key":"10.1016\/j.beem.2018.06.004_bib69","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM197406202902504","article-title":"Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation","volume":"290","author":"Craddock","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM198508153130705","article-title":"Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure","volume":"313","author":"Aubier","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib71","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0002-9343(88)90065-4","article-title":"Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population","volume":"84","author":"Gravelyn","year":"1988","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib72","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-8703(84)90337-5","article-title":"Left ventricular function in patients with chronic hypophosphatemia","volume":"107","author":"Vered","year":"1984","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.beem.2018.06.004_bib73","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM197710272971702","article-title":"Effect of hypophosphatemia on myocardial performance in man","volume":"297","author":"O'Connor","year":"1977","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.5650050508","article-title":"Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study","volume":"5","author":"Vered","year":"1990","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib75","first-page":"335","article-title":"[Acute polyneuropathy due to phosphate deficiency during parenteral feeding]","volume":"97","author":"Junge","year":"1979","journal-title":"Fortschr Med"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib76","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp.74.6.820","article-title":"Central pontine myelinolysis temporally related to hypophosphataemia","volume":"74","author":"Michell","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0016-5085(72)80032-5","article-title":"Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation","volume":"62","author":"Silvis","year":"1972","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib78","first-page":"135","article-title":"Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders","volume":"134","author":"Chesney","year":"1980","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1995.tb02621.x","article-title":"Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features","volume":"43","author":"Clarke","year":"1995","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10067-014-2627-x","article-title":"Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients","volume":"35","author":"Mateo","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"13","key":"10.1016\/j.beem.2018.06.004_bib81","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM198809293191307","article-title":"Elevated serum 1,25-dihydroxyvitamin D concentrations in siblings with primary Fanconi's syndrome","volume":"319","author":"Tieder","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib82","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","article-title":"A\u00a0loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome","volume":"362","author":"Magen","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib83","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib84","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2783","article-title":"1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"issue":"18","key":"10.1016\/j.beem.2018.06.004_bib85","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","article-title":"Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets","volume":"303","author":"Glorieux","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib86","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02079060","article-title":"Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia","volume":"154","author":"Haffner","year":"1995","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib87","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with x-linked hypophosphatemia: effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/SCS.0b013e31819b9868","article-title":"X-linked hypophosphatemic rickets and craniosynostosis","volume":"20","author":"Murthy","year":"2009","journal-title":"J\u00a0Craniofac Surg"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","article-title":"Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice","volume":"85","author":"Liang","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib91","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI111900","article-title":"Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol","volume":"75","author":"Harrell","year":"1985","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib92","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A\u00a0clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib93","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI119276","article-title":"Pex\/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice","volume":"99","author":"Beck","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/hmg\/6.2.165","article-title":"Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia","volume":"6","author":"Strom","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib95","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0002-9440(10)64468-9","article-title":"An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets","volume":"161","author":"Carpinelli","year":"2002","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00335-003-2310-z","article-title":"New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice","volume":"15","author":"Lorenz-Depiereux","year":"2004","journal-title":"Mamm Genome"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-007-9199-6","article-title":"A\u00a0novel Phex mutation with defective glycosylation causes hypophosphatemia and rickets in mice","volume":"15","author":"Xiong","year":"2008","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.beem.2018.06.004_bib98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1423-0127-18-60","article-title":"Kbus\/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'","volume":"18","author":"Moriyama","year":"2011","journal-title":"J\u00a0Biomed Sci"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A\u00a0gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium","volume":"11","year":"1995","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/hmg\/6.4.539","article-title":"Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)","volume":"6","author":"Rowe","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib101","first-page":"790","article-title":"Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets","volume":"60","author":"Holm","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"22","key":"10.1016\/j.beem.2018.06.004_bib102","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.273.22.13729","article-title":"Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity","volume":"273","author":"Lipman","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib103","first-page":"722","article-title":"Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia","volume":"118","author":"Yuan","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1096\/fasebj.11.5.9141502","article-title":"Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX","volume":"11","author":"Turner","year":"1997","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pages","year":"2004","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib107","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1359\/jbmr.080601","article-title":"MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM","volume":"23","author":"Addison","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib108","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/me.2002-0113","article-title":"Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression","volume":"16","author":"Bai","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib109","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in\u00a0vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib112","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/endo-123-2-768","article-title":"Defective bone formation by transplanted Hyp mouse bone cells into normal mice","volume":"123","author":"Ecarot-Charrier","year":"1988","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib113","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/8756-3282(92)90199-7","article-title":"Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3","volume":"13","author":"Yamamoto","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.004_bib114","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","article-title":"Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes","volume":"102","author":"Sabbagh","year":"2005","journal-title":"Proc Natl Acad Sci."},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jcb.22302","article-title":"Phosphate regulates embryonic endochondral bone development","volume":"108","author":"Zalutskaya","year":"2009","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.beem.2018.06.004_bib116","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.1074\/jbc.M109.098616","article-title":"Phosphate-induced apoptosis of hypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon ERK1\/2 phosphorylation","volume":"285","author":"Miedlich","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib117","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1210\/en.2014-1315","article-title":"Phosphate interacts with PTHrP to regulate endochondral bone formation","volume":"155","author":"Liu","year":"2014","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib118","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI81928","article-title":"CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders","volume":"126","author":"Bai","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib119","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib120","first-page":"1165","article-title":"Growth hormone therapy in hypophosphatemic rickets","volume":"145","author":"Wilson","year":"1991","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib121","first-page":"212","article-title":"Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets","volume":"69","author":"Makitie","year":"2008","journal-title":"Horm Res"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.1999.00680.x","article-title":"A\u00a0trial of growth hormone therapy in well-controlled hypophosphataemic rickets","volume":"50","author":"Cameron","year":"1999","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib123","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.100.5.879","article-title":"The effect of recombinant human growth hormone in children with X-linked hypophosphatemia","volume":"100","author":"Seikaly","year":"1997","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib124","first-page":"839","article-title":"Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia","volume":"76","author":"Friedman","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"26","key":"10.1016\/j.beem.2018.06.004_bib125","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","article-title":"Effects of therapy in X-linked hypophosphatemic rickets","volume":"325","author":"Verge","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","article-title":"The enigma of hyperparathyroidism in hypophosphatemic rickets","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib127","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib128","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1210\/en.2012-1551","article-title":"Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice","volume":"153","author":"Karaplis","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib129","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib130","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with x-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib131","article-title":"Burosuman, a fully human anti-FGF23 monoclonal antibody, for X-linked hypophosphatemia (XLH): results from two phase 2 trials in affected children 1-12 years old","volume":"39","author":"Whyte","year":"2018","journal-title":"Endocr Rev"},{"issue":"21","key":"10.1016\/j.beem.2018.06.004_bib132","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib133","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib134","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib135","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI119809","article-title":"Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13","volume":"100","author":"Econs","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib136","first-page":"305","article-title":"Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation","volume":"55","author":"Kruse","year":"2001","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib137","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bone.2012.11.012","article-title":"Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood","volume":"52","author":"Seton","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib138","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib139","first-page":"103","article-title":"[Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family]","volume":"64","author":"Negri","year":"2004","journal-title":"Medicina (B Aires)."},{"issue":"1\u20132","key":"10.1016\/j.beem.2018.06.004_bib140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-1119(00)00050-0","article-title":"Molecular cloning of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a candidate autosomal dominant hypophosphatemic rickets (ADHR) gene","volume":"246","author":"White","year":"2000","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib141","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00774-011-0285-5","article-title":"FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets","volume":"30","author":"Sun","year":"2012","journal-title":"J\u00a0Bone Miner Metabol"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib142","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in\u00a0vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib143","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib144","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","article-title":"The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment","volume":"26","author":"Lu","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib146","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","article-title":"Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene","volume":"86","author":"Levy-Litan","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib147","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib148","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A\u00a0patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib149","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11914-014-0223-2","article-title":"Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis","volume":"12","author":"White","year":"2014","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib150","doi-asserted-by":"crossref","first-page":"e32177","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1(-\/-) mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib151","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jbmr.1850","article-title":"Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification","volume":"28","author":"Rafaelsen","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib152","doi-asserted-by":"crossref","first-page":"e1002708","DOI":"10.1371\/journal.pgen.1002708","article-title":"Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice","volume":"8","author":"Wang","year":"2012","journal-title":"PLoS Genet"},{"issue":"6085","key":"10.1016\/j.beem.2018.06.004_bib153","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1217817","article-title":"Secreted kinase phosphorylates extracellular proteins that regulate biomineralization","volume":"336","author":"Tagliabracci","year":"2012","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib154","doi-asserted-by":"crossref","first-page":"e42988","DOI":"10.1371\/journal.pone.0042988","article-title":"The Raine syndrome protein FAM20C is a Golgi kinase that phosphorylates bio-mineralization proteins","volume":"7","author":"Ishikawa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2018.06.004_bib155","series-title":"GeneReviews(R)","article-title":"Fibrous dysplasia\/McCune-Albright syndrome","author":"Boyce","year":"1993"},{"issue":"24","key":"10.1016\/j.beem.2018.06.004_bib156","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2018.06.004_bib157","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1359\/jbmr.06s223","article-title":"G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2018.06.004_bib158","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","article-title":"McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia","volume":"7","author":"Collins","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib159","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","article-title":"The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome","volume":"23","author":"Yamamoto","year":"2005","journal-title":"J\u00a0Bone Miner Metabol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib160","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib161","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib162","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.joms.2016.04.001","article-title":"Osteonecrosis of the jaw","volume":"74","author":"Metwally","year":"2016","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib163","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib164","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pediatrneurol.2007.10.012","article-title":"Linear nevus sebaceous syndrome: case reports and review of the literature","volume":"38","author":"Menascu","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib165","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1210\/jc.2013-2813","article-title":"Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23","volume":"99","author":"Avitan-Hersh","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib166","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib167","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/en.2010-0354","article-title":"The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice","volume":"151","author":"Miedlich","year":"2010","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.beem.2018.06.004_bib168","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","article-title":"Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities","volume":"95","author":"Beck","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.beem.2018.06.004_bib169","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter","volume":"347","author":"Prie","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib170","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/sj.ki.5000437","article-title":"NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak","volume":"69","author":"Lapointe","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib171","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria","volume":"312","author":"Tieder","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib172","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM198701153160302","article-title":"\u201cIdiopathic\u201d hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect","volume":"316","author":"Tieder","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib173","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib174","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib175","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","article-title":"Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis","volume":"25","author":"Dasgupta","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib176","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1210\/jc.2009-1535","article-title":"Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3\/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis","volume":"94","author":"Tencza","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.004_bib177","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197310182891601","article-title":"Pathogenesis of hereditary vitamin-D-dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1a,25-dihydroxyvitamin D","volume":"289","author":"Fraser","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.004_bib178","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM197805042981804","article-title":"Vitamin D-dependent rickets Type II: resistance of target organs to 1,25-Dihydroxyvitamin D","volume":"298","author":"Brooks","year":"1978","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib179","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem-50-5-927","article-title":"Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone","volume":"50","author":"Fujita","year":"1980","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib180","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI98680","article-title":"CYP3A4 mutation causes vitamin D-dependent rickets type 3","volume":"128","author":"Roizen","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib181","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jc.2016-4048","article-title":"CYP3A4 induction by Rifampin: an alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations","volume":"102","author":"Hawkes","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2018.06.004_bib182","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib183","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting","volume":"86","author":"White","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.beem.2018.06.004_bib184","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib185","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib186","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib187","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","article-title":"The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23","volume":"27","author":"White","year":"2006","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib188","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/en.2010-1351","article-title":"Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis","volume":"152","author":"Christov","year":"2011","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib189","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","article-title":"Tumor-induced osteomalacia","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.99.5.745","article-title":"Hyperostosis with hyperphosphatemia: evidence of familial occurrence and association with tumoral calcinosis","volume":"99","author":"Narchi","year":"1997","journal-title":"Pediatrics"},{"issue":"5637","key":"10.1016\/j.beem.2018.06.004_bib191","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.1.5637.142-a","article-title":"Tumoral calcinosis\u2013an unrecognized disease","volume":"1","author":"McClatchie","year":"1969","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib192","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2106\/00004623-197860080-00025","article-title":"Tumoral calcinosis. A clinical and pathological study of eleven unreported cases in Turkey","volume":"60","author":"Hacihanefioglu","year":"1978","journal-title":"J\u00a0Bone Joint Surg Am."},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib193","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002340050763","article-title":"Familial tumoral calcinosis: association with cerebral and peripheral aneurysm formation","volume":"41","author":"Adams","year":"1999","journal-title":"Neuroradiology"},{"issue":"18","key":"10.1016\/j.beem.2018.06.004_bib194","first-page":"30123","article-title":"Dialysis as a treatment option for a patient with normal kidney function and familial tumoral calcinosis due to a compound heterozygous FGF23 mutation","volume":"14","author":"Goldenstein","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib195","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000478-199308000-00004","article-title":"Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis","volume":"17","author":"Slavin","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib196","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/0003-4819-77-5-741","article-title":"Treatment of tumoral calcinosis with phosphorus deprivation","volume":"77","author":"Mozaffarian","year":"1972","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib197","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2106\/00004623-198971080-00019","article-title":"Tumoral calcinosis: successful medical treatment. A case report","volume":"71","author":"Gregosiewicz","year":"1989","journal-title":"J\u00a0Bone Joint Surg Am."},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib198","first-page":"178","article-title":"Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer","volume":"71","author":"Lammoglia","year":"2009","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib199","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ajmg.a.36476","article-title":"Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms","volume":"164A","author":"Finer","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib201","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A\u00a0novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"27","key":"10.1016\/j.beem.2018.06.004_bib202","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib203","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib204","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10038-006-0377-6","article-title":"Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred","volume":"51","author":"Specktor","year":"2006","journal-title":"J\u00a0Hum Genet"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg","year":"2005","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.beem.2018.06.004_bib207","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene","volume":"91","author":"Ichikawa","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.06.004_bib208","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2006-1825","article-title":"Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations","volume":"92","author":"Ichikawa","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.06.004_bib209","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A\u00a0homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.004_bib210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-0-387-77576-0_3","article-title":"The GNAS locus and pseudohypoparathyroidism","volume":"626","author":"Bastepe","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"20","key":"10.1016\/j.beem.2018.06.004_bib211","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1073\/pnas.95.20.11798","article-title":"The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3","volume":"95","author":"Juppner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.beem.2018.06.004_bib212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40618-016-0588-4","article-title":"Pseudohypoparathyroidism: one gene, several syndromes","volume":"40","author":"Tafaj","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib213","first-page":"330","article-title":"Hypo-phosphataemia in children under five years with kwashiorkor and marasmic kwashiorkor","volume":"86","author":"Kimutai","year":"2009","journal-title":"East Afr Med J"},{"issue":"6","key":"10.1016\/j.beem.2018.06.004_bib214","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(98)70153-2","article-title":"Severe hypophosphatemia in children with kwashiorkor is associated with increased mortality","volume":"133","author":"Manary","year":"1998","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.beem.2018.06.004_bib215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jbmr.5650010107","article-title":"Renal adaptation to phosphorus deprivation: characterization of early events","volume":"1","author":"Levine","year":"1986","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1016\/j.beem.2018.06.004_bib216","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.beem.2018.06.004_bib217","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM196802222780802","article-title":"Evidence for a phosphorus-depletion syndrome in man","volume":"278","author":"Lotz","year":"1968","journal-title":"N\u00a0Engl J Med"},{"issue":"5924","key":"10.1016\/j.beem.2018.06.004_bib218","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmj.3.5924.150","article-title":"Iatrogenic osteomalacia and myopathy due to phosphate depletion","volume":"3","author":"Baker","year":"1974","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.beem.2018.06.004_bib219","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00774-010-0232-x","article-title":"Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomy","volume":"29","author":"Yamauchi","year":"2011","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.beem.2018.06.004_bib220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11657-014-0177-0","article-title":"Osteomalacia in Crohn's disease","volume":"9","author":"Dedeoglu","year":"2014","journal-title":"Arch Osteoporos."},{"issue":"3","key":"10.1016\/j.beem.2018.06.004_bib221","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0016-5085(85)90156-8","article-title":"Vitamin D metabolism and osteomalacia in cystic fibrosis","volume":"88","author":"Friedman","year":"1985","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.beem.2018.06.004_bib222","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/oby.2011.133","article-title":"Increased PTH and 1.25(OH)(2)D levels associated with increased markers of bone turnover following bariatric surgery","volume":"19","author":"Sinha","year":"2011","journal-title":"Obesity (Silver Spring)."}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:17Z","timestamp":1761497597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":222,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18300861"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphate homeostasis disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}